To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers

NCT05383131 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: HEC585
DRUG: Pirfenidone
DRUG: Nintedanib

Sponsor

Sunshine Lake Pharma Co., Ltd.